Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high-incidence country.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 09 2023
Historique:
revised: 04 04 2023
received: 25 11 2022
accepted: 04 05 2023
medline: 21 7 2023
pubmed: 1 6 2023
entrez: 1 6 2023
Statut: ppublish

Résumé

Since 2006, Chile has been implementing a gallbladder cancer (GBC) prevention program based on prophylactic cholecystectomy for gallstone patients aged 35 to 49 years. The effectiveness of this prevention program has not yet been comprehensively evaluated. We conducted a retrospective study of 473 Chilean GBC patients and 2137 population-based controls to develop and internally validate three GBC risk prediction models. The Baseline Model accounted for gallstones while adjusting for sex and birth year. Enhanced Model I also included the non-genetic risk factors: body mass index, educational level, Mapuche surnames, number of children and family history of GBC. Enhanced Model II further included Mapuche ancestry and the genotype for rs17209837. Multiple Cox regression was applied to assess the predictive performance, quantified by the area under the precision-recall curve (AUC-PRC) and the number of cholecystectomies needed (NCN) to prevent one case of GBC at age 70 years. The AUC-PRC for the Baseline Model (0.44%, 95%CI 0.42-0.46) increased by 0.22 (95%CI 0.15-0.29) when non-genetic factors were included, and by 0.25 (95%CI 0.20-0.30) when incorporating non-genetic and genetic factors. The overall NCN for Chileans with gallstones (115, 95%CI 104-131) decreased to 92 (95%CI 60-128) for Chileans with a higher risk than the median according to Enhanced Model I, and to 80 (95%CI 59-110) according to Enhanced Model II. In conclusion, age, sex and gallstones are strong risk factors for GBC, but consideration of other non-genetic factors and individual genotype data improves risk prediction and may optimize allocation of financial resources and surgical capacity.

Identifiants

pubmed: 37260300
doi: 10.1002/ijc.34607
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1151-1161

Informations de copyright

© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Global Cancer Observatory. International Agency for Research on Cancer. World Health Organization; 2019. https://gco.iarc.fr/
Health Ministry of Chile. Problema de Salud AUGE N 26. Cholecistectomía Preventiva Del cáncer De Vésicula En Personas De 35 a 49 años, 2015.
Latorre SG, Ivanovic-Zuvic SD, Corsi SO, et al. Coverage of the gallbladder cancer prevention strategy in Chile: results from the 2009-2010 National Health Survey. Revista medica de Chile. 2015;143:158-167.
Health Ministry of Chile: Department of Statistics and Health Information in Chile. Data publically available. https://deis.minsal.cl/
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.
Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons; 1987:166-167.
Brand JPL. Development, implementation, and evaluation of multiple imputation strategies for the statistical analysis of incomplete data sets. Erasmus University; 1999:57-60. https://pure.eur.nl/en/publications/development-implementation-and-evaluation-of-multiple-imputation-
Bustos BI, Perez-Palma E, Buch S, et al. Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche native American ancestry. Sci Rep. 2019;9:772.
Health Ministry of Chile. Personal Communication. 2018.
Boekstegers F, Marcelain K, Barahona Ponce C, et al. ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. Cancer Epidemiol. 2020;65:101643.
Lange K, Sinsheimer JS, Sobel E. Association testing with Mendel. Genet Epidemiol. 2005;29:36-50.
Lange K, Papp JC, Sinsheimer JS, Sripracha R, Zhou H, Sobel EM. Mendel: the Swiss army knife of genetic analysis programs. Bioinformatics. 2013;29:1568-1570.
Efron B, Tibshirani R. Improvements on cross-validation: the .632+ bootstrap method. J Am Stat Assoc. 1997;92:548-560.
Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS One. 2015;10:e0118432.
van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19:3401-3415.
Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med. 2004;23:1631-1660.
International Agency for Research on Cancer (IARC). Cancer Today; 2020. https://gco.iarc.fr/today/home
Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in mendelian randomization studies. Int J Epidemiol. 2013;42:1497-1501.
Lowenfels AB, Lindstrom CG, Conway MJ, Hastings PR. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst. 1985;75:77-80.
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99-109.
Addeo P, Centonze L, Locicero A, et al. Incidental gallbladder carcinoma discovered after laparoscopic cholecystectomy: identifying patients who will benefit from reoperation. J Gastrointest Surg. 2018;22:606-614.

Auteurs

Felix Boekstegers (F)

Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.

Dominique Scherer (D)

Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.

Carol Barahona Ponce (C)

Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.

Katherine Marcelain (K)

Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Santiago, Chile.

Valentina Gárate-Calderón (V)

Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Santiago, Chile.

Melanie Waldenberger (M)

Research Unit of Molecular Epidemiology and Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Erik Morales (E)

Hospital Regional de Talca, Talca, Chile.
Facultad de Medicina, Universidad Católica del Maule, Talca, Chile.

Armando Rojas (A)

Facultad de Medicina, Universidad Católica del Maule, Talca, Chile.

César Munoz (C)

Hospital Regional de Talca, Talca, Chile.
Facultad de Medicina, Universidad Católica del Maule, Talca, Chile.

Javier Retamales (J)

Instituto Nacional del Cáncer, Santiago, Chile.

Gonzalo de Toro (G)

Hospital de Puerto Montt, Puerto Montt, Chile.
Escuela de Tecnología Médica, Universidad Austral de Chile sede Puerto Montt, Puerto Montt, Chile.

Olga Barajas (O)

Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Santiago, Chile.
Hospital Clínico Universidad de Chile, Santiago, Chile.

María Teresa Rivera (MT)

Hospital del Salvador, Santiago, Chile.

Analía Cortés (A)

Hospital del Salvador, Santiago, Chile.

Denisse Loader (D)

Hospital Padre Hurtado, Santiago, Chile.

Javiera Saavedra (J)

Hospital Padre Hurtado, Santiago, Chile.

Lorena Gutiérrez (L)

Hospital San Juan de Dios, Santiago, Chile.

Alejandro Ortega (A)

Hospital Regional, Arica, Chile.

Maria Enriqueta Bertrán (ME)

Unidad Registro Hospitalario de Cáncer, Hospital Base de Valdivia, Valdivia, Chile.

Leonardo Bartolotti (L)

Hospital Base de Valdivia, Chile.

Fernando Gabler (F)

Hospital San Borja Arriarán, Santiago, Chile.

Mónica Campos (M)

Hospital San Borja Arriarán, Santiago, Chile.

Juan Alvarado (J)

Hospital Regional Guillermo Grant Benavente, Concepción, Chile.

Fabricio Moisán (F)

Hospital Regional Guillermo Grant Benavente, Concepción, Chile.

Loreto Spencer (L)

Hospital Regional Guillermo Grant Benavente, Concepción, Chile.

Bruno Nervi (B)

Departamento de Hematología y Oncología, Escuela de Medicina Pontificia Universidad Católica de Chile, Santiago, Chile.

Daniel Carvajal-Hausdorf (D)

Facultad de Medicina, Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.

Héctor Losada (H)

Departamento de Cirugía, Universidad de La Frontera, Temuco, Chile.

Mauricio Almau (M)

Hospital de Rancagua, Rancagua, Chile.

Plinio Fernández (P)

Hospital de Rancagua, Rancagua, Chile.

Jordi Olloquequi (J)

Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.

Macarena Fuentes-Guajardo (M)

Departamento de Tecnología Médica, Facultad de Ciencias de la Salud, Tarapacá University, Arica, Chile.

Rolando Gonzalez-Jose (R)

Instituto Patagónico de Ciencias Sociales y Humanas, Centro Nacional Patagónico, CONICET, Puerto Madryn, Argentina.

Maria Cátira Bortolini (MC)

Departamento de Genética, Instituto de Biociências, Universidad Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Victor Acuña-Alonzo (V)

National Institute of Anthropology and History, Mexico City, Mexico.

Carla Gallo (C)

Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.

Andres Ruiz Linares (AR)

Ministry of Education Key Laboratory of Contemporary Anthropology and Collaborative Innovation Center of Genetics and Development, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China.
Aix-Marseille Université, CNRS, EFS, ADES, Marseille, France.
Department of Genetics, Evolution and Environment, and UCL Genetics Institute, University College London, London, UK.

Francisco Rothhammer (F)

Instituto de Alta Investigación, Tarapacá University, Arica, Chile.

Justo Lorenzo Bermejo (J)

Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Department of Biostatistics for Precision Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH